Joseph Klein III's Net Worth
$8.77 Million
Who is Joseph Klein III?
Joseph Klein III has an estimated net worth of $8.77 Million. This is based on reported shares across multiple companies, which include GENAISSANCE PHARMACEUTICALS INC, SAVIENT PHARMACEUTICALS INC, BIOMARIN PHARMACEUTICAL INC, IONIS PHARMACEUTICALS INC, AKCEA THERAPEUTICS, INC., NPS PHARMACEUTICALS INC, PDL BIOPHARMA, INC., CLINICAL DATA INC, OSI PHARMACEUTICALS INC, and GUILFORD PHARMACEUTICALS INC.
SEC CIK
Joseph Klein III's CIK is 0001206369
Past Insider Trading and Trends
2006 was Joseph Klein III's most active year for acquiring shares with 35 total transactions. Joseph Klein III's most active month to acquire stocks was the month of June. 2008 was Joseph Klein III's most active year for disposing of shares, totalling 53 transactions. Joseph Klein III's most active month to dispose stocks was the month of June. 2008 saw Joseph Klein III paying a total of $1,437,142.25 for 146,400 shares, this is the most they've acquired in one year. In 2010 Joseph Klein III cashed out on 57,595 shares for a total of $2,533,078.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENAISSANCE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -56.79K |
—
|
—
|
0
|
Oct 6
| |||
Form 4
| +15.42% | 7.59K |
—
|
—
| 56.79K |
Jun 30
| |||
Form 4
| +23.00% | 9.2K |
—
|
—
| 49.2K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
∞
| 40K |
$1.30 | $52,018.00 | 40K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SAVIENT PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -16.81% | -3.51K |
—
|
—
| 17.39K |
Jun 8
| |||
Form 4
| +25.33% | 3.51K |
$11.38 | $39,989.32 | 17.39K |
Jun 8
| |||
Form 4
| +115.90% | 7.45K |
$5.37 | $39,995.76 | 13.87K |
May 5
| |||
Form 4
| -38.37% | -4.00K |
$26.47 | -$105,880.00 | 6.43K |
Jun 2
| |||
Form 4
| -27.73% | -4.00K |
$24.07 | -$96,280.00 | 10.43K |
May 27
| |||
Form 4
| -21.71% | -4.00K |
$22.67 | -$90,680.00 | 14.43K |
May 19
| |||
Form 4
| +9.65% | 1.62K |
$24.66 | $39,998.52 | 18.43K |
May 13
| |||
Form 4
| -19.23% | -4.00K |
$24.59 | -$98,360.00 | 16.8K |
May 12
| |||
Form 4
| -27.77% | -8.00K |
$22.81 | -$182,440.00 | 20.8K |
May 1 - May 5
| |||
Form 4
| -40.98% | -20.00K |
—
|
—
| 28.8K |
Jun 1
| |||
Form 4
| +7.20% | 3.28K |
$12.77 | $41,847.29 | 48.8K |
May 15
| |||
Form 4
| +0.69% | 311 |
$12.02 | $3,738.22 | 45.53K |
Mar 30
| |||
Form 4/A
| +0.74% | 334 |
$11.21 | $3,744.14 | 45.22K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
| +1.30% | 576 |
$6.51 | $3,749.76 | 44.88K |
Sep 29
| |||
Form 4
| +7.26% | 3K |
$6.30 | $18,900.00 | 44.31K |
Scheduled
|
Sep 15
| ||
Form 4
| +7.83% | 3K |
$6.50 | $19,494.00 | 41.31K |
Scheduled
|
Sep 1
| ||
Form 4
| +8.50% | 3K |
$5.79 | $17,370.00 | 38.31K |
Scheduled
|
Aug 15
| ||
Form 4
| +9.29% | 3K |
$5.88 | $17,640.00 | 35.31K |
Scheduled
|
Aug 1
| ||
Form 4
| +10.24% | 3K |
$5.19 | $15,570.00 | 32.31K |
Scheduled
|
Jul 18
| ||
Form 4/A
| +1.18% | 306 |
$5.25 | $1,606.50 | 26.31K |
Jun 30
| |||
Form 4
| +1.18% | 306 |
$5.25 | $1,606.50 | 26.31K |
Jun 30
| |||
Form 4
| +11.54% | 3K |
$5.34 | $16,020.00 | 29K |
Scheduled
|
Jul 3
| ||
Form 4
| +13.04% | 3K |
$5.71 | $17,130.00 | 26K |
Scheduled
|
Jun 15
| ||
Form 4
| +15.00% | 3K |
$5.83 | $17,502.00 | 23K |
Scheduled
|
Jun 1
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.22% | -10.00K |
$22.12 | -$221,227.00 | 35K |
Mar 8
| |||
Form 4
| +5.56% | 2.5K |
—
|
—
| 47.5K |
May 22
| |||
Form 4
| +5.88% | 2.5K |
—
|
—
| 45K |
May 12
| |||
Form 4
| +13.33% | 5K |
$10.07 | $50,363.00 | 42.5K |
Mar 5
| |||
Form 4
| +15.38% | 5K |
$10.56 | $52,817.50 | 37.5K |
Mar 3
| |||
Form 4
| +44.44% | 10K |
$12.08 | $120,784.00 | 32.5K |
Feb 24
| |||
Form 4
| +12.50% | 2.5K |
—
|
—
| 22.5K |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4/A
| +100.00% | 10K |
$26.07 | -$332,033.30 | 20K |
Feb 29 - Mar 3
| |||
Form 4
| +200.00% | 20K |
$26.12 | $45,966.70 | 30K |
Feb 29 - Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| -100.00% | -12.00K |
$16.37 | -$196,397.03 |
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
∞
| 10K |
$11.62 | -$78,720.00 | 10K |
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
No matching records found |
IONIS PHARMACEUTICALS INC (IONS) Snapshot price: $46.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$37.21 | -$306,960.00 |
0
|
Scheduled
|
Jul 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| -100.00% | -6.00K |
$42.71 | -$256,276.57 |
0
|
Scheduled
|
May 3
| ||
Form 4
| -10.90% | -2.00K |
$50.00 | -$100,000.00 | 16.35K |
Scheduled
|
Nov 15
| ||
Form 4
| -9.83% | -2.00K |
$45.13 | -$90,253.60 | 18.35K |
Sep 26
| |||
Form 4
| +21.17% | 3.56K |
$42.00 | -$149,310.00 | 20.35K |
Jul 17 - Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
| -10.64% | -2.00K |
$40.00 | -$80,000.00 | 16.79K |
Scheduled
|
Jan 17
| ||
Form 4
| +54.96% | 6.67K |
$38.24 | -$50,977.18 | 18.79K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +31.40% | 4.33K |
$35.30 | -$152,989.33 | 18.13K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| -17.32% | -2.89K |
$46.86 | -$135,385.76 | 13.79K |
Scheduled
|
Oct 20
| ||
Form 4
| +31.54% | 4K |
—
|
—
| 16.68K |
Jul 1 - Jul 6
| |||
Form 4
|
—
|
0
|
$48.70 | -$26,344.20 | 12.68K |
Scheduled
|
Dec 23
| ||
Form 4
|
—
|
0
|
$50.49 | -$29,916.50 | 12.68K |
Scheduled
|
Dec 16
| ||
Form 4
|
—
|
0
|
$49.64 | -$28,214.70 | 12.68K |
Scheduled
|
Dec 9
| ||
Form 4
|
—
|
0
|
$49.81 | -$28,553.00 | 12.68K |
Scheduled
|
Dec 2
| ||
Form 4
| -6.02% | -812.00 |
$62.90 | -$51,074.80 | 12.68K |
Scheduled
|
Nov 25
| ||
Form 4
| -12.91% | -2.00K |
$60.00 | -$120,000.00 | 13.49K |
Scheduled
|
Nov 20
| ||
Form 4
| +22.92% | 2.89K |
—
|
—
| 15.49K |
Jul 1 - Jul 3
| |||
Form 4
| +26.83% | 2.67K |
—
|
—
| 12.61K |
Jul 1 - Jul 3
| |||
Form 4
|
—
|
0
|
$35.28 | -$43,460.00 | 9.94K |
Scheduled
|
Mar 29
| ||
Form 4
|
—
|
0
|
$37.78 | -$53,418.00 | 9.94K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
$43.72 | -$49,137.00 | 9.94K |
Scheduled
|
Feb 28
| ||
Form 4
|
—
|
0
|
$42.26 | -$40,394.00 | 9.94K |
Scheduled
|
Feb 15
| ||
Form 4/A
|
—
|
0
|
$44.20 | -$51,990.00 | 9.94K |
Scheduled
|
Jan 30
| ||
Form 4
|
—
|
0
|
$44.03 | -$50,976.00 | 9.94K |
Scheduled
|
Jan 16
| ||
Form 4
|
—
|
0
|
$39.52 | -$66,270.00 | 9.94K |
Scheduled
|
Dec 29
| ||
Form 4
|
—
|
0
|
$40.08 | -$69,660.00 | 9.94K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
$41.01 | -$75,240.00 | 9.94K |
Scheduled
|
Nov 30
| ||
Form 4
| +39.46% | 2.81K |
$36.70 | -$20,065.22 | 9.94K |
Scheduled
|
Nov 15 - Nov 16
| ||
Form 4
| -29.62% | -3.00K |
$55.39 | -$166,170.00 | 7.13K |
Scheduled
|
Nov 13
| ||
Form 4
| +32.24% | 2.47K |
—
|
—
| 10.13K |
Jul 1 - Jul 3
| |||
Form 4
| +38.16% | 2.12K |
—
|
—
| 7.66K |
Jul 1 - Jul 2
| |||
Form 4
|
—
|
0
|
$37.57 | -$365,921.56 | 5.54K |
Nov 11
| |||
Form 4
| +35.36% | 1.45K |
—
|
—
| 5.54K |
Jul 1 - Jul 2
| |||
Form 4
| +273.97% | 3K |
$40.57 | -$394,881.50 | 4.09K |
Mar 5
| |||
Form 4
| -64.62% | -2.00K |
—
|
—
| 1.09K |
Feb 11
| |||
Form 4
| +33.81% | 782 |
—
|
—
| 3.1K |
Jul 1 - Jul 2
| |||
Form 4
|
—
|
0
|
$32.03 | -$343,038.02 | 2.31K |
Jan 24
| |||
Form 4
| -72.18% | -6.00K |
$36.86 | -$221,156.40 | 2.31K |
Nov 25
| |||
Form 4
|
—
|
0
|
$19.20 | -$338,176.03 | 8.31K |
Aug 9
| |||
Form 4
| +3.91% | 313 |
—
|
—
| 8.31K |
Jul 1 - Jul 2
| |||
Form 4
|
—
|
0
|
$15.80 | -$17,275.18 |
0
|
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
$13.68 | -$318,693.82 | 200 |
Scheduled
|
Mar 19 - Mar 20
| ||
Form 4
|
—
|
0
|
$11.61 | -$266,399.52 | 100 |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| -55.56% | -10.00K |
$18.58 | -$185,798.50 | 8K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
| +12.50% | 2K |
$6.26 | $12,520.00 | 18K |
Scheduled
|
Aug 15
| ||
Form 4
| +14.29% | 2K |
$6.00 | $12,000.00 | 16K |
Scheduled
|
Aug 1
| ||
Form 4
| +16.67% | 2K |
$5.91 | $11,820.00 | 14K |
Scheduled
|
Jul 18
| ||
Form 4
| +20.00% | 2K |
$6.02 | $12,040.00 | 12K |
Scheduled
|
Jul 3
| ||
Form 4
| +25.00% | 2K |
$6.40 | $12,800.00 | 10K |
Scheduled
|
Jun 15
| ||
Form 4
| +33.33% | 2K |
$5.48 | $10,960.00 | 8K |
Scheduled
|
Feb 1
| ||
Form 4
| +50.00% | 2K |
$5.46 | $10,920.00 | 6K |
Scheduled
|
Jan 17
| ||
Form 4
| +100.00% | 2K |
$5.16 | $10,321.00 | 4K |
Scheduled
|
Jan 3
| ||
Form 4
|
∞
| 2K |
$5.18 | $10,360.00 | 2K |
Scheduled
|
Dec 13 - Dec 15
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AKCEA THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |